Antimicrobial prophylaxis in adult cardiac surgery in the United Kingdom and Republic of Ireland
- PMID: 33859725
- PMCID: PMC8014008
- DOI: 10.1177/1757177420971850
Antimicrobial prophylaxis in adult cardiac surgery in the United Kingdom and Republic of Ireland
Abstract
Background: Deep sternal wound infections are a financially costly complication of cardiac surgery with serious implications for patient morbidity and mortality. Prophylactic antimicrobials have been shown to reduce the incidence of infection significantly. In 2018, the European Association for CardioThoracic Surgery (EACTS) provided clear guidance advising that third-generation cephalosporins are the first-line prophylactic antimicrobial of choice for cardiac surgery via median sternotomy as a result of their broad spectrum of activity and association with reduced postoperative mortality. Despite this guidance, it was believed that UK practice differed from this as a consequence of national concerns surrounding cephalosporins use and Clostridioides difficile infection.
Methods: A survey was developed and distributed to all UK and Republic of Ireland (ROI) cardiac surgery centres in January 2019 to quantify this variation.
Results: Of the 38 centres, 34 responded. Variation existed between the antimicrobial agent used, as well as the dosage, frequency and duration of suggested regimens even among centres using the same antimicrobial agent. The most common antimicrobial prophylaxis prescribed was a combination of flucloxacillin and gentamicin (16, 47%). Followed by cefuroxime (6, 17.6%) and cefuroxime combined with a glycopeptide (4, 11.7%). In patients colonised with methicillin-resistant Staphylococcus aureus or those with penicillin allergy gentamicin combined with teicoplanin was most common (42% and 50%, respectively).
Discussion: This variation in antimicrobial agents and regimens may well contribute to the varying incidence of surgical site infection seen across the UK and ROI.
Keywords: Cardiac surgery; Clostridioides difficile; Clostridium difficile; adult; antimicrobial prophylaxis; cephalosporins; deep sternal wound infection; infection prevention; surgical site infection.
© The Author(s) 2020.
Conflict of interest statement
Declaration of conflicting interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Figures


References
-
- Bartlett JG, Gerding DN. (2008) Clinical Recognition and Diagnosis of Clostridium difficile Infection. Clinical Infectious Diseases 46: S12–S18. - PubMed
-
- Bratzler DW, Houck PM, Surgical Infection Prevention Guidelines Writers Workgroup, American Academy of Orthopaedic Surgeons, American Association of Critical Care Nurses, American Association of Nurse Anesthetists, American College of Surgeons, American College of Osteopathic Surgeons, American Geriatrics Society, American Society of Anesthesiologists, American Society of Colon and Rectal Surgeons, American Society of Health-System Pharmacists, American Society of Perianesthesia Nurses, Ascension Health, Association of Perioperative Registered Nurses, Association for Professionals in Infection Control and Epidemiology, Infectious Diseases Society of America, Medical Letter, Premier, Society for Healthcare Epidemiology of America, Society of Thoracic Surgeons and Surgical Infection Society. (2004) Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Clinical Infectious Diseases 38: 1706–1715. - PubMed
-
- Cardiothoracic Interdisciplinary Research Network, Rogers L, Vaja R, Bleetman D, Ali JM, Rochon M, Sanders J, Tanner J, Lamagni TL, Talukder S, Quijano-Campos JC, Lai F, Loubani M, Murphy G. (2019) Interventions to prevent surgical site infection in adults undergoing cardiac surgery. Cochrane Database of Systematic Reviews 2019: CD013332.
LinkOut - more resources
Full Text Sources
Medical